Last Close
May 18  •  04:00PM ET
32.31
Dollar change
+0.24
Percentage change
0.75
%
May 14, 10:00 AMStaar Surgical beats Q1 2026 estimates as China rebound restores profitability and Wedbush upgrades to Outperform, lifts target to $40
Index
RUT
P/E
-
EPS (ttm)
-0.43
Insider Own
33.36%
Shs Outstand
49.40M
Perf Week
16.10%
Market Cap
1.60B
Forward P/E
33.77
EPS next Y
0.96
Insider Trans
18.72%
Shs Float
32.99M
Perf Month
28.83%
Enterprise Value
1.47B
PEG
-
EPS next Q
0.22
Inst Own
75.86%
Perf Quarter
99.44%
Income
-21.03M
P/S
5.51
EPS this Y
165.20%
Inst Trans
-7.77%
Perf Half Y
24.13%
Sales
290.38M
P/B
4.53
EPS next Y
46.73%
ROA
-4.63%
Perf YTD
39.93%
Book/sh
7.13
P/C
9.76
EPS next 5Y
-
ROE
-5.99%
52W High
35.87 -9.92%
Perf Year
68.11%
Cash/sh
3.31
P/FCF
-
EPS past 3/5Y
- -
ROIC
-5.48%
52W Low
15.59 107.31%
Perf 3Y
-49.44%
Dividend Est.
-
EV/EBITDA
42.59
Sales past 3/5Y
-5.57% 7.93%
Gross Margin
75.13%
Volatility
7.23% 4.89%
Perf 5Y
-71.55%
Dividend TTM
-
EV/Sales
5.07
EPS Y/Y TTM
70.55%
Oper. Margin
9.05%
ATR (14)
1.61
Perf 10Y
487.45%
Dividend Ex-Date
-
Quick Ratio
4.31
Sales Y/Y TTM
4.03%
Profit Margin
-7.24%
RSI (14)
79.18
Dividend Gr. 3/5Y
- -
Current Ratio
5.12
EPS Q/Q
109.31%
SMA20
17.30%
Beta
1.23
Payout
-
Debt/Eq
0.11
Sales Q/Q
119.59%
SMA50
38.50%
Rel Volume
0.79
Prev Close
32.07
Employees
957
LT Debt/Eq
0.09
SMA200
34.50%
Avg Volume
1.32M
Price
32.31
IPO
Jul 07, 1983
Option/Short
Yes / Yes
Trades
Volume
1,037,144
Change
0.75%
Date Action Analyst Rating Change Price Target Change
May-14-26Upgrade Wedbush Neutral → Outperform $40
Apr-09-26Upgrade Canaccord Genuity Hold → Buy $27
Feb-03-26Initiated Wedbush Neutral $26
Jan-16-26Resumed Morgan Stanley Underweight $13
Apr-21-25Initiated Wells Fargo Equal Weight $17
Feb-12-25Downgrade William Blair Outperform → Mkt Perform
Feb-12-25Downgrade Mizuho Outperform → Neutral $45 → $17
Feb-12-25Downgrade Jefferies Buy → Hold
Feb-12-25Downgrade BTIG Research Buy → Neutral
Jul-15-24Downgrade Morgan Stanley Equal-Weight → Underweight $50 → $37
May-14-26 09:45AM
01:03AM
May-13-26 04:13PM
04:01PM
May-04-26 04:01PM
01:32PM Loading…
Apr-09-26 01:32PM
06:26AM
Apr-08-26 04:01PM
Mar-17-26 06:57AM
Mar-04-26 08:30AM
12:02AM
Mar-03-26 07:02PM
05:15PM
04:34PM
04:21PM
04:02PM Loading…
04:02PM
04:01PM
Mar-02-26 09:36AM
Feb-26-26 05:30PM
Feb-25-26 04:01PM
Feb-24-26 12:31PM
08:31AM
Feb-23-26 04:01PM
08:46AM
08:45AM
Feb-19-26 12:08PM
Feb-18-26 05:18AM
Feb-17-26 04:01PM
Feb-09-26 11:37PM
Feb-05-26 10:00AM
07:55AM Loading…
07:55AM
Feb-04-26 01:27PM
Feb-03-26 10:00AM
09:34AM
05:23AM
Feb-02-26 12:55PM
07:00AM
Jan-30-26 01:00PM
Jan-25-26 08:18PM
Jan-23-26 04:35PM
Jan-16-26 08:39PM
09:32AM
08:02AM
05:00AM
Jan-15-26 11:04PM
01:06PM
08:30AM
Jan-13-26 08:45AM
Jan-07-26 07:38AM
Jan-06-26 08:00PM
12:32PM
12:14PM
09:52AM
08:47AM
06:13AM
Dec-19-25 03:51PM
12:59PM
11:45AM
Dec-17-25 06:47PM
04:53PM
01:17PM
10:55AM
Dec-16-25 03:58PM
01:32PM
09:12AM
07:00AM
Dec-15-25 06:35PM
Dec-12-25 05:29PM
08:40AM
Dec-11-25 08:06PM
11:41AM
09:47AM
07:00AM
Dec-10-25 01:34PM
07:05AM
Dec-09-25 02:25PM
02:16PM
12:39PM
12:00PM
08:30AM
Dec-08-25 04:11PM
01:28PM
08:16AM
08:00AM
Dec-04-25 10:35PM
Dec-03-25 12:02PM
Dec-02-25 04:14PM
Nov-26-25 03:34PM
Nov-18-25 04:15PM
Nov-12-25 02:35PM
Nov-10-25 06:38PM
01:00PM
08:00AM
Nov-07-25 04:22PM
10:10AM
Nov-06-25 06:21AM
Nov-05-25 04:27PM
04:01PM
Nov-04-25 11:32PM
03:13PM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Interim Co-CEO & CFOMs. Deborah J. Andrews
Interim Co-CEOMr. Warren Foust
Chief Development OfficerDr. Magda Michna Ph.D.
Director of Investor RelationsMs. Connie Johnson
Chief Marketing OfficerMs. Nancy Sabin
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foust WarrenInterim Co-CEO and Pres. & COOMar 14 '26Option Exercise0.0029,325063,588Mar 16 05:00 PM
Foust WarrenInterim Co-CEO and Pres. & COOMar 12 '26Option Exercise0.008,175034,263Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 14 '26Option Exercise0.0017,595036,001Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 12 '26Option Exercise0.006,178020,622Mar 16 05:00 PM
BROADWOOD PARTNERS, L.P.DirectorMar 13 '26Buy18.61316,0175,882,65616,123,842Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 12 '26Buy18.12299,4325,424,33015,807,825Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 11 '26Buy17.5254,764959,55815,508,393Mar 13 07:59 PM
Jiang WeiDirectorJan 12 '26Option Exercise0.0020,967066,444Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 09 '26Buy22.0527,485606,13815,453,629Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 06 '26Buy21.62336,9467,284,28115,356,437Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 07 '26Buy22.0066,4671,462,30115,422,904Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 08 '26Buy21.943,24071,08215,426,144Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 21 '25Buy27.86797,48622,218,83715,019,491Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 20 '25Buy27.14393,38210,675,32514,222,005Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 19 '25Buy26.42309,1328,166,15513,828,623Nov 21 09:55 PM
Jiang WeiDirectorNov 12 '25Option Exercise0.0020,967045,477Nov 14 06:00 PM
Jiang WeiDirectorAug 12 '25Option Exercise0.0020,967024,510Aug 13 06:39 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.871,75047,025Aug 05 06:38 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.8713,491362,523Aug 05 06:33 PM